Mechanisms of action of neuropeptide Y on stem cells and its potential applications in orthopaedic disorders

doi:10.4252/wjsc.v12.i9.986

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6254)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

313

WORD

188

HTML

3423

Figures (1-2)

577

Tables (1-1)

191

Sum=4692

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

552

Download

1010

Sum=1562

Sep 26, 2020 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Sep 26, 2020; 12(9): 986-1000
Published online Sep 26, 2020. doi: 10.4252/wjsc.v12.i9.986

Table 1 Effects of neuropeptide Y receptor-targeted drugs on bone metabolism

Antagonist	Bone phenotype	Administration and subjects
Y1R antagonist BIBP3226[56]	Callus tissue volume ↓, callus bone volume and callus ↓, BV/TV↓	Intraperitoneal injection
Y1R antagonist BIBP3226[56]		Sprague-Dawley rats
Y2R antagonist JNJ-31020028[79]	Vertebral trabecular bone volume ↑, bone mineral density ↑, trabecular thickness ↑; P1NP and CTX biomarkers ↓	Intraperitoneal injection
Y2R antagonist JNJ-31020028[79]		Ovariectomized Mice
Y1R antagonist BIBO3304[80]	Osteoblast activity ↑, cortical and cancellous bone volumes ↑; no adverse effects	Oral administration
Y1R antagonist BIBO3304[80]		Mice

P1NP: Procollagen type 1 N-terminal pro-peptide; CTX: Collagen type I C-telopeptide; BV/TV: Bone volume/total volume.

Citation: Wu JQ, Jiang N, Yu B. Mechanisms of action of neuropeptide Y on stem cells and its potential applications in orthopaedic disorders. World J Stem Cells 2020; 12(9): 986-1000
URL: https://www.wjgnet.com/1948-0210/full/v12/i9/986.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i9.986